61 Biggest Movers From Yesterday
Gainers
Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
Intellia Therapeutics Analyst Doubles Price Target: What You Need To Know
An SVB Leerink genetic medicine analyst is bullish on shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA). Here's why.
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04.
Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump
Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50.
44 Stocks Moving In Monday’s Mid-Day Session
Gainers
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy.
Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook
Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58.
Benzinga Pro’s Top 5 Stocks To Watch For Monday, Jun. 28, 2021: CCL, NTLA, DDL, PRVB, WBA
Today's 5 Stock Ideas
Carnival (CCL) - Shares were down 2% following news the company registered an offering of $500 million in common stock for a shelf.
Intellia Therapeutics (NTLA) - The
Why Intellia Therapeutics Stock Is Soaring Today
Intellia Therapeutics Inc (NASDAQ: NTLA) is trading significantly higher Monday morning after the company announced positive clinical data for its CRISPR therapy.
10 Biggest Price Target Changes For Monday
Barclays raised the price target for Accenture plc (NYSE: ACN) from $310 to $335. Accenture shares rose 1.1% to close at $294.66 on Friday.